Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	JUN kinase binding	SPAG9 KIF5B MAPK8IP3	3.60e-06	17	36	3	GO:0008432
GeneOntologyMolecularFunction	ATP hydrolysis activity	SMARCA4 KIF5B SRCAP CLPB ATP8B2 SMC1B RSF1	1.17e-05	441	36	7	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	SMARCA4 SRCAP RSF1	4.01e-05	37	36	3	GO:0140658
GeneOntologyMolecularFunction	ATP-dependent activity	SMARCA4 KIF5B SRCAP CLPB ATP8B2 SMC1B RSF1	9.64e-05	614	36	7	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal protein binding	CEP350 PPARGC1A ROCK1 SPAG9 KIF5B PSTPIP1 NEXN ADD3 MAPK8IP3	1.09e-04	1099	36	9	GO:0008092
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA2 NCOA1 PPARGC1A	1.18e-04	53	36	3	GO:0030331
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	NCOA2 NCOA1 PPARGC1A	1.80e-04	61	36	3	GO:0030374
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA2 SMARCA4 NCOA1 PPARGC1A SRCAP	2.00e-04	303	36	5	GO:0003713
GeneOntologyMolecularFunction	MAP-kinase scaffold activity	SPAG9 MAPK8IP3	2.43e-04	13	36	2	GO:0005078
GeneOntologyMolecularFunction	nuclear receptor binding	NCOA2 SMARCA4 NCOA1 PPARGC1A	3.47e-04	187	36	4	GO:0016922
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	SMARCA4 KIF5B SRCAP CLPB ATP8B2 SMC1B RSF1	4.03e-04	775	36	7	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	SMARCA4 KIF5B SRCAP CLPB ATP8B2 SMC1B RSF1	6.47e-04	839	36	7	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	SMARCA4 KIF5B SRCAP CLPB ATP8B2 SMC1B RSF1	6.52e-04	840	36	7	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	SMARCA4 KIF5B SRCAP CLPB ATP8B2 SMC1B RSF1	6.52e-04	840	36	7	GO:0016818
GeneOntologyMolecularFunction	DNA polymerase binding	NCOA2 SMARCA4	7.81e-04	23	36	2	GO:0070182
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA2 NCOA1	7.81e-04	23	36	2	GO:0046965
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOA2 SMARCA4 NCOA1 PPARGC1A SPAG9 TCHH SRCAP MAPK8IP3	8.90e-04	1160	36	8	GO:0030674
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	SMARCA4 SRCAP RSF1	1.54e-03	127	36	3	GO:0008094
GeneOntologyMolecularFunction	lncRNA binding	SMARCA4 PPARGC1A	1.81e-03	35	36	2	GO:0106222
GeneOntologyMolecularFunction	molecular adaptor activity	NCOA2 SMARCA4 NCOA1 PPARGC1A SPAG9 TCHH SRCAP MAPK8IP3	2.42e-03	1356	36	8	GO:0060090
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA2 SMARCA4 NCOA1 PPARGC1A SRCAP	3.18e-03	562	36	5	GO:0003712
GeneOntologyMolecularFunction	histone acetyltransferase activity	NCOA1 SRCAP	3.81e-03	51	36	2	GO:0004402
GeneOntologyMolecularFunction	signaling receptor complex adaptor activity	SPAG9 MAPK8IP3	4.26e-03	54	36	2	GO:0030159
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	NCOA1 SRCAP	4.42e-03	55	36	2	GO:0061733
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	NCOA2 NCOA1	4.42e-03	55	36	2	GO:0042974
GeneOntologyMolecularFunction	kinesin binding	SPAG9 MAPK8IP3	4.42e-03	55	36	2	GO:0019894
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	NCOA1 SRCAP	5.24e-03	60	36	2	GO:0034212
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	NCOA2 SMARCA4 NCOA1 PPARGC1A	6.51e-03	417	36	4	GO:0061629
GeneOntologyMolecularFunction	actin filament binding	PSTPIP1 NEXN ADD3	7.85e-03	227	36	3	GO:0051015
GeneOntologyMolecularFunction	N-acetyltransferase activity	NCOA1 SRCAP	8.71e-03	78	36	2	GO:0008080
GeneOntologyBiologicalProcess	cellular response to Thyroglobulin triiodothyronine	NCOA2 NCOA1	1.49e-05	4	33	2	GO:1904017
GeneOntologyBiologicalProcess	positive regulation of female receptivity	NCOA2 NCOA1	1.49e-05	4	33	2	GO:0045925
GeneOntologyBiologicalProcess	neuron projection development	TNIK ROCK1 SPAG9 UPF3B KIF5B ITGA4 HLA-C NEXN MINK1 MAPK8IP3	2.10e-05	1285	33	10	GO:0031175
GeneOntologyBiologicalProcess	neuron projection morphogenesis	TNIK ROCK1 SPAG9 KIF5B ITGA4 NEXN MINK1 MAPK8IP3	2.95e-05	802	33	8	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	TNIK ROCK1 SPAG9 KIF5B ITGA4 NEXN MINK1 MAPK8IP3	3.43e-05	819	33	8	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	TNIK ROCK1 SPAG9 KIF5B ITGA4 NEXN MINK1 MAPK8IP3	3.64e-05	826	33	8	GO:0048858
GeneOntologyBiologicalProcess	response to Thyroglobulin triiodothyronine	NCOA2 NCOA1	3.71e-05	6	33	2	GO:1904016
GeneOntologyBiologicalProcess	positive regulation of neuron differentiation	NCOA1 SPAG9 UPF3B MAPK8IP3	4.31e-05	123	33	4	GO:0045666
GeneOntologyBiologicalProcess	regulation of neuron differentiation	NCOA1 ROCK1 SPAG9 UPF3B MAPK8IP3	4.97e-05	255	33	5	GO:0045664
GeneOntologyBiologicalProcess	neuron development	TNIK ROCK1 SPAG9 UPF3B KIF5B ITGA4 HLA-C NEXN MINK1 MAPK8IP3	6.38e-05	1463	33	10	GO:0048666
GeneOntologyBiologicalProcess	mRNA metabolic process	NCOA2 NCOA1 PPARGC1A ROCK1 UPF3B TRMT6 NSRP1 RBM17	7.62e-05	917	33	8	GO:0016071
GeneOntologyBiologicalProcess	cell morphogenesis	TNIK SMARCA4 ROCK1 SPAG9 KIF5B ITGA4 NEXN MINK1 MAPK8IP3	7.71e-05	1194	33	9	GO:0000902
GeneOntologyBiologicalProcess	anterograde axonal protein transport	KIF5B MAPK8IP3	8.87e-05	9	33	2	GO:0099641
GeneOntologyBiologicalProcess	regulation of female receptivity	NCOA2 NCOA1	8.87e-05	9	33	2	GO:0045924
GeneOntologyBiologicalProcess	axo-dendritic protein transport	KIF5B MAPK8IP3	1.35e-04	11	33	2	GO:0099640
GeneOntologyBiologicalProcess	protein localization to presynapse	KIF5B MAPK8IP3	1.35e-04	11	33	2	GO:1905383
GeneOntologyBiologicalProcess	female mating behavior	NCOA2 NCOA1	1.62e-04	12	33	2	GO:0060180
GeneOntologyBiologicalProcess	positive regulation of adipose tissue development	NCOA2 NCOA1	2.23e-04	14	33	2	GO:1904179
GeneOntologyBiologicalProcess	adipose tissue development	NCOA2 NCOA1 PPARGC1A	2.72e-04	79	33	3	GO:0060612
GeneOntologyBiologicalProcess	microtubule-based protein transport	KIF5B MAPK8IP3	3.33e-04	17	33	2	GO:0099118
GeneOntologyBiologicalProcess	protein transport along microtubule	KIF5B MAPK8IP3	3.33e-04	17	33	2	GO:0098840
GeneOntologyBiologicalProcess	regulation of adipose tissue development	NCOA2 NCOA1	5.11e-04	21	33	2	GO:1904177
GeneOntologyBiologicalProcess	regulation of cell migration	SMARCA4 PPARGC1A ROCK1 SPAG9 ITGA4 NEXN MINK1 MAPK8IP3	5.12e-04	1211	33	8	GO:0030334
GeneOntologyBiologicalProcess	lysosome localization	SPAG9 KIF5B CPLX2	6.61e-04	107	33	3	GO:0032418
GeneOntologyBiologicalProcess	vacuolar localization	SPAG9 KIF5B CPLX2	6.61e-04	107	33	3	GO:1990849
GeneOntologyBiologicalProcess	positive regulation of JNK cascade	TNIK MINK1 MAPK8IP3	6.61e-04	107	33	3	GO:0046330
GeneOntologyBiologicalProcess	regulation of cell motility	SMARCA4 PPARGC1A ROCK1 SPAG9 ITGA4 NEXN MINK1 MAPK8IP3	7.40e-04	1280	33	8	GO:2000145
GeneOntologyBiologicalProcess	protein localization to synapse	TNIK KIF5B MAPK8IP3	8.15e-04	115	33	3	GO:0035418
GeneOntologyBiologicalProcess	microvillus assembly	TNIK MINK1	9.14e-04	28	33	2	GO:0030033
GeneOntologyBiologicalProcess	labyrinthine layer morphogenesis	NCOA1 ITGA4	9.14e-04	28	33	2	GO:0060713
GeneOntologyBiologicalProcess	peroxisome proliferator activated receptor signaling pathway	NCOA2 NCOA1	9.14e-04	28	33	2	GO:0035357
GeneOntologyBiologicalProcess	regulation of locomotion	SMARCA4 PPARGC1A ROCK1 SPAG9 ITGA4 NEXN MINK1 MAPK8IP3	9.37e-04	1327	33	8	GO:0040012
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	TNIK KIF5B ITGA4 NEXN MINK1 MAPK8IP3	1.07e-03	748	33	6	GO:0048667
GeneOntologyCellularComponent	nuclear chromosome	SMARCA4 SRCAP INCENP SMC1B ADD3	7.06e-05	254	36	5	GO:0000228
GeneOntologyCellularComponent	lateral element	INCENP SMC1B	4.84e-04	19	36	2	GO:0000800
GeneOntologyCellularComponent	condensed nuclear chromosome	INCENP SMC1B ADD3	5.14e-04	91	36	3	GO:0000794
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	SMARCA4 SRCAP RSF1	6.00e-04	96	36	3	GO:0070603
GeneOntologyCellularComponent	somatodendritic compartment	NCOA2 PPARGC1A UPF3B KIF5B ITGA4 MINK1 MAPK8IP3 CPLX2	9.58e-04	1228	36	8	GO:0036477
GeneOntologyCellularComponent	centriolar satellite	SPAG9 UPF3B KIF5B	1.38e-03	128	36	3	GO:0034451
GeneOntologyCellularComponent	ATPase complex	SMARCA4 SRCAP RSF1	1.41e-03	129	36	3	GO:1904949
GeneOntologyCellularComponent	condensed chromosome	SMARCA4 INCENP SMC1B ADD3	1.86e-03	307	36	4	GO:0000793
GeneOntologyCellularComponent	synaptonemal complex	INCENP SMC1B	2.85e-03	46	36	2	GO:0000795
GeneOntologyCellularComponent	synaptonemal structure	INCENP SMC1B	2.85e-03	46	36	2	GO:0099086
GeneOntologyCellularComponent	dendrite	NCOA2 PPARGC1A KIF5B MINK1 MAPK8IP3 CPLX2	3.19e-03	858	36	6	GO:0030425
GeneOntologyCellularComponent	dendritic tree	NCOA2 PPARGC1A KIF5B MINK1 MAPK8IP3 CPLX2	3.23e-03	860	36	6	GO:0097447
GeneOntologyCellularComponent	axon	KIF5B ITGA4 NEXN MINK1 MAPK8IP3 CPLX2	3.84e-03	891	36	6	GO:0030424
Domain	JIP_LZII	SPAG9 MAPK8IP3	3.41e-06	2	35	2	IPR032486
Domain	JIP_LZII	SPAG9 MAPK8IP3	3.41e-06	2	35	2	PF16471
Domain	DUF1518	NCOA2 NCOA1	1.02e-05	3	35	2	PF07469
Domain	DUF1518	NCOA2 NCOA1	1.02e-05	3	35	2	IPR010011
Domain	Src1_rcpt_coact	NCOA2 NCOA1	1.02e-05	3	35	2	IPR008955
Domain	Nuclear_rcpt_coactivator	NCOA2 NCOA1	1.02e-05	3	35	2	IPR017426
Domain	DUF1518	NCOA2 NCOA1	1.02e-05	3	35	2	SM01151
Domain	Nuc_rcpt_coact_Ncoa-typ	NCOA2 NCOA1	1.02e-05	3	35	2	IPR014920
Domain	SRC-1	NCOA2 NCOA1	1.02e-05	3	35	2	IPR014935
Domain	SRC-1	NCOA2 NCOA1	1.02e-05	3	35	2	PF08832
Domain	-	NCOA2 NCOA1	1.02e-05	3	35	2	4.10.630.10
Domain	Nuc_rec_co-act	NCOA2 NCOA1	1.02e-05	3	35	2	PF08815
Domain	HSA	SMARCA4 SRCAP	2.04e-05	4	35	2	SM00573
Domain	Jnk-SapK_ap_N	SPAG9 MAPK8IP3	2.04e-05	4	35	2	PF09744
Domain	HSA	SMARCA4 SRCAP	2.04e-05	4	35	2	PS51204
Domain	HSA_dom	SMARCA4 SRCAP	2.04e-05	4	35	2	IPR014012
Domain	JNK/Rab-associated_protein-1_N	SPAG9 MAPK8IP3	2.04e-05	4	35	2	IPR019143
Domain	HSA	SMARCA4 SRCAP	2.04e-05	4	35	2	PF07529
Domain	RH2	SPAG9 MAPK8IP3	3.40e-05	5	35	2	PS51777
Domain	RH1	SPAG9 MAPK8IP3	3.40e-05	5	35	2	PS51776
Domain	Nuc_rcpt_coact	NCOA2 NCOA1	5.09e-05	6	35	2	IPR009110
Domain	CNH	TNIK MINK1	3.06e-04	14	35	2	SM00036
Domain	CNH	TNIK MINK1	3.53e-04	15	35	2	PS50219
Domain	CNH_dom	TNIK MINK1	3.53e-04	15	35	2	IPR001180
Domain	CNH	TNIK MINK1	3.53e-04	15	35	2	PF00780
Domain	PAS	NCOA2 NCOA1	9.96e-04	25	35	2	PF00989
Domain	PAS_fold	NCOA2 NCOA1	9.96e-04	25	35	2	IPR013767
Domain	SNF2_N	SMARCA4 SRCAP	1.63e-03	32	35	2	PF00176
Domain	SNF2_N	SMARCA4 SRCAP	1.63e-03	32	35	2	IPR000330
Domain	PAS	NCOA2 NCOA1	1.63e-03	32	35	2	SM00091
Domain	PAS	NCOA2 NCOA1	1.84e-03	34	35	2	IPR000014
Domain	PAS	NCOA2 NCOA1	1.84e-03	34	35	2	PS50112
Domain	-	PPARGC1A UPF3B RBM17	1.06e-02	244	35	3	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	PPARGC1A UPF3B RBM17	1.23e-02	258	35	3	IPR012677
Pathway	PID_ERB_GENOMIC_PATHWAY	NCOA2 SMARCA4 NCOA1	3.89e-06	15	30	3	M119
Pathway	PID_BETA_CATENIN_NUC_PATHWAY	TNIK NCOA2 SMARCA4 INCENP	2.36e-05	80	30	4	M223
Pathway	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	NCOA2 NCOA1 PPARGC1A	3.76e-05	31	30	3	M39476
Pathway	WP_PREGNANE_X_RECEPTOR_PATHWAY	NCOA2 NCOA1 PPARGC1A	4.14e-05	32	30	3	M39567
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	NCOA2 NCOA1 PPARGC1A	1.09e-04	44	30	3	M27295
Pathway	BIOCARTA_PPARG_PATHWAY	NCOA1 PPARGC1A	1.22e-04	8	30	2	M22058
Pathway	REACTOME_HEME_SIGNALING	NCOA2 NCOA1 PPARGC1A	1.50e-04	49	30	3	M41832
Pathway	PID_ARF6_TRAFFICKING_PATHWAY	SPAG9 ITGA4 MAPK8IP3	1.50e-04	49	30	3	M67
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	NCOA2 NCOA1 PPARGC1A	2.12e-04	55	30	3	M27145
Pathway	KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	NCOA2 NCOA1	2.38e-04	11	30	2	M47503
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL	NCOA2 NCOA1	3.92e-04	14	30	2	M27074
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL	NCOA2 NCOA1	3.92e-04	14	30	2	MM14748
Pathway	REACTOME_CIRCADIAN_CLOCK	NCOA2 NCOA1 PPARGC1A	4.32e-04	70	30	3	M938
Pathway	REACTOME_SUMOYLATION	NCOA2 NCOA1 PPARGC1A INCENP	6.53e-04	189	30	4	M27214
Pathway	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	NCOA2 NCOA1	6.56e-04	18	30	2	M4862
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 NCOA1	6.56e-04	18	30	2	MM15034
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA2 NCOA1	6.56e-04	18	30	2	M26942
Pathway	PID_REG_GR_PATHWAY	NCOA2 SMARCA4 NCOA1	6.88e-04	82	30	3	M115
Pathway	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	NCOA2 NCOA1	7.32e-04	19	30	2	MM14612
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	NCOA2 NCOA1 PPARGC1A	7.38e-04	84	30	3	M1008
Pathway	WP_ANDROGEN_RECEPTOR_SIGNALING	NCOA2 NCOA1 ROCK1	9.31e-04	91	30	3	M39700
Pathway	WP_HIPPOYAP_SIGNALING	TNIK MINK1	9.85e-04	22	30	2	M39821
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	NCOA2 NCOA1	1.08e-03	23	30	2	M1926
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	NCOA2 NCOA1	1.08e-03	23	30	2	MM14741
Pathway	REACTOME_MITOCHONDRIAL_BIOGENESIS	NCOA2 NCOA1 PPARGC1A	1.09e-03	96	30	3	M26973
Pathway	BIOCARTA_VDR_PATHWAY	SMARCA4 NCOA1	1.17e-03	24	30	2	M13404
Pathway	REACTOME_ENDOGENOUS_STEROLS	NCOA2 NCOA1	1.27e-03	25	30	2	M11184
Pathway	REACTOME_ENDOGENOUS_STEROLS	NCOA2 NCOA1	1.49e-03	27	30	2	MM14844
Pathway	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION	NCOA2 NCOA1	1.49e-03	27	30	2	M26943
Pathway	REACTOME_ADIPOGENESIS	NCOA2 NCOA1 PPARGC1A	1.61e-03	110	30	3	M48259
Pathway	PID_RETINOIC_ACID_PATHWAY	NCOA2 NCOA1	1.84e-03	30	30	2	M207
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION	NCOA1 PPARGC1A	1.96e-03	31	30	2	M48258
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 NCOA1 PPARGC1A	1.97e-03	118	30	3	M27316
Pathway	REACTOME_RHO_GTPASE_EFFECTORS	NCOA2 ROCK1 KIF5B INCENP	2.04e-03	257	30	4	MM14755
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	NCOA2 NCOA1	2.22e-03	33	30	2	M5967
Pathway	PID_NCADHERIN_PATHWAY	ROCK1 KIF5B	2.22e-03	33	30	2	M266
Pathway	PID_INTEGRIN_A4B1_PATHWAY	ITGA4 ADAM28	2.22e-03	33	30	2	M277
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	NCOA2 NCOA1	2.22e-03	33	30	2	MM14737
Pathway	WP_ADIPOGENESIS	NCOA2 NCOA1 PPARGC1A	2.65e-03	131	30	3	M39505
Pathway	REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	TNIK MINK1	2.78e-03	37	30	2	MM14899
Pathway	WP_ADIPOGENESIS_GENES	NCOA2 NCOA1 PPARGC1A	3.01e-03	137	30	3	MM15970
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	NCOA2 NCOA1	3.58e-03	42	30	2	M27172
Pathway	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	NCOA2 NCOA1	3.92e-03	44	30	2	M499
Pathway	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	NCOA2 NCOA1	4.09e-03	45	30	2	MM14751
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CEP350 NCOA2 ROCK1 SPAG9 UPF3B KIF5B CCDC59 SRCAP INCENP RSF1	7.39e-10	645	36	10	25281560
Pubmed	Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.	NCOA2 NCOA1 PPARGC1A	4.07e-09	4	36	3	17513608
Pubmed	Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor.	NCOA2 NCOA1 PPARGC1A	1.02e-08	5	36	3	18798693
Pubmed	A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.	NCOA2 NCOA1 PPARGC1A	1.02e-08	5	36	3	15026545
Pubmed	A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.	NCOA2 NCOA1 PPARGC1A	2.03e-08	6	36	3	16373399
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TNIK SMARCA4 SPAG9 UPF3B KIF5B SRCAP NSRP1 ADD3 RSF1 RBM17	2.51e-08	934	36	10	33916271
Pubmed	Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.	NCOA2 SMARCA4 NCOA1	3.55e-08	7	36	3	9590696
Pubmed	Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.	NCOA2 NCOA1 PPARGC1A	5.68e-08	8	36	3	23178929
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CEP350 TNIK SMARCA4 UPF3B TRMT6 KIF5B CCDC59 CLPB HLA-C ADD3 RBM17	8.31e-08	1371	36	11	36244648
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 NCOA1 PPARGC1A	1.67e-07	11	36	3	36613751
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	NCOA2 SMARCA4 NCOA1	6.86e-07	17	36	3	19183483
Pubmed	Structural characterization of the RH1-LZI tandem of JIP3/4 highlights RH1 domains as a cytoskeletal motor-binding motif.	SPAG9 MAPK8IP3	1.04e-06	2	36	2	31690808
Pubmed	The lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin alpha4beta1.	ITGA4 ADAM28	1.04e-06	2	36	2	11724793
Pubmed	JIP3 interacts with dynein and kinesin-1 to regulate bidirectional organelle transport.	KIF5B MAPK8IP3	1.04e-06	2	36	2	35829703
Pubmed	SRC-1 and TIF2 control energy balance between white and brown adipose tissues.	NCOA2 NCOA1	1.04e-06	2	36	2	12507421
Pubmed	Overlapping roles of JIP3 and JIP4 in promoting axonal transport of lysosomes in human iPSC-derived neurons.	SPAG9 MAPK8IP3	1.04e-06	2	36	2	33788575
Pubmed	Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction.	NCOA2 NCOA1	1.04e-06	2	36	2	15070739
Pubmed	Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency.	NCOA2 NCOA1	1.04e-06	2	36	2	11897715
Pubmed	Microenvironmental Interaction Between Hypoxia and Endothelial Cells Controls the Migration Ability of Placenta-Derived Mesenchymal Stem Cells via α4 Integrin and Rho Signaling.	ROCK1 ITGA4	1.04e-06	2	36	2	26448639
Pubmed	Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness.	NCOA2 NCOA1	1.04e-06	2	36	2	15231721
Pubmed	Distinct steady-state nuclear receptor coregulator complexes exist in vivo.	NCOA2 NCOA1	1.04e-06	2	36	2	9751728
Pubmed	Ncoa2 Promotes CD8+ T cell-Mediated Antitumor Immunity by Stimulating T-cell Activation via Upregulation of PGC-1α Critical for Mitochondrial Function.	NCOA2 PPARGC1A	1.04e-06	2	36	2	37540802
Pubmed	Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis.	NCOA2 NCOA1	1.04e-06	2	36	2	25148457
Pubmed	Morphogenesis of the telencephalic commissure requires scaffold protein JNK-interacting protein 3 (JIP3).	ROCK1 SPAG9 MAPK8IP3	1.15e-06	20	36	3	12897243
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA2 NCOA1 PPARGC1A	1.34e-06	21	36	3	19596656
Pubmed	Negative modulation of androgen receptor transcriptional activity by Daxx.	NCOA2 NCOA1 PPARGC1A	1.55e-06	22	36	3	15572661
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	TNIK ROCK1 ITGA4 HLA-C ADD3 MINK1	2.31e-06	377	36	6	38117590
Pubmed	The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles.	NCOA2 NCOA1	3.12e-06	3	36	2	21035760
Pubmed	Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.	NCOA2 NCOA1	3.12e-06	3	36	2	24550004
Pubmed	Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.	NCOA2 NCOA1	3.12e-06	3	36	2	21059860
Pubmed	RORgammat recruits steroid receptor coactivators to ensure thymocyte survival.	NCOA2 NCOA1	3.12e-06	3	36	2	16148126
Pubmed	Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse.	NCOA2 NCOA1	3.12e-06	3	36	2	16914740
Pubmed	Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.	NCOA2 NCOA1	3.12e-06	3	36	2	16675958
Pubmed	Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.	NCOA2 NCOA1	3.12e-06	3	36	2	9506940
Pubmed	Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.	NCOA2 NCOA1	3.12e-06	3	36	2	28390937
Pubmed	SNF2-related CBP activator protein (SRCAP) functions as a coactivator of steroid receptor-mediated transcription through synergistic interactions with CARM-1 and GRIP-1.	NCOA2 SRCAP	3.12e-06	3	36	2	14500758
Pubmed	The role of SRC1 and SRC2 in steroid-induced SDF1 expression in normal and ectopic endometrium.	NCOA2 NCOA1	3.12e-06	3	36	2	24586072
Pubmed	Steroid receptor coactivator 2 is essential for progesterone-dependent uterine function and mammary morphogenesis: insights from the mouse--implications for the human.	NCOA2 NCOA1	3.12e-06	3	36	2	17045797
Pubmed	Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences.	NCOA2 NCOA1	3.12e-06	3	36	2	23927929
Pubmed	The scaffold protein JIP3 functions as a downstream effector of the small GTPase ARF6 to regulate neurite morphogenesis of cortical neurons.	SPAG9 MAPK8IP3	3.12e-06	3	36	2	20493856
Pubmed	JSAP1/JIP3 and JLP regulate kinesin-1-dependent axonal transport to prevent neuronal degeneration.	SPAG9 MAPK8IP3	3.12e-06	3	36	2	25571974
Pubmed	Identification of ROCK1 as an upstream activator of the JIP-3 to JNK signaling axis in response to UVB damage.	ROCK1 MAPK8IP3	3.12e-06	3	36	2	19036714
Pubmed	Recurrent MEIS1-NCOA2/1 fusions in a subset of low-grade spindle cell sarcomas frequently involving the genitourinary and gynecologic tracts.	NCOA2 NCOA1	3.12e-06	3	36	2	33574497
Pubmed	Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.	NCOA2 NCOA1	3.12e-06	3	36	2	18845648
Pubmed	The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP.	NCOA2 NCOA1	3.12e-06	3	36	2	12138202
Pubmed	MINK is a Rap2 effector for phosphorylation of the postsynaptic scaffold protein TANC1.	TNIK MINK1	3.12e-06	3	36	2	18930710
Pubmed	Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain.	NCOA2 NCOA1	3.12e-06	3	36	2	14757047
Pubmed	Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer.	NCOA1 PPARGC1A	3.12e-06	3	36	2	21757690
Pubmed	Structure and chromosomal locations of mouse steroid receptor coactivator gene family.	NCOA2 NCOA1	3.12e-06	3	36	2	10501088
Pubmed	Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators.	NCOA2 NCOA1	3.12e-06	3	36	2	12114525
Pubmed	JSAP1 and JLP are required for ARF6 localization to the midbody in cytokinesis.	SPAG9 MAPK8IP3	3.12e-06	3	36	2	25130574
Pubmed	Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice.	NCOA2 NCOA1	3.12e-06	3	36	2	15983373
Pubmed	The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.	NCOA2 NCOA1	3.12e-06	3	36	2	16423883
Pubmed	Critical role of JSAP1 and JLP in axonal transport in the cerebellar Purkinje cells of mice.	SPAG9 MAPK8IP3	3.12e-06	3	36	2	26320416
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	TNIK ROCK1 ITGA4 HLA-C ADD3 MINK1	4.35e-06	421	36	6	36976175
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	SMARCA4 UPF3B KIF5B CCDC59 HLA-C NEXN NSRP1 RBM17	4.58e-06	949	36	8	36574265
Pubmed	miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.	NCOA2 NCOA1	6.24e-06	4	36	2	26066330
Pubmed	Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.	NCOA2 NCOA1	6.24e-06	4	36	2	11818499
Pubmed	Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins.	NCOA2 NCOA1	6.24e-06	4	36	2	10454563
Pubmed	P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.	NCOA2 NCOA1	6.24e-06	4	36	2	18267973
Pubmed	Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells.	NCOA2 NCOA1	6.24e-06	4	36	2	15331759
Pubmed	Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex.	NCOA2 NCOA1	6.24e-06	4	36	2	12024042
Pubmed	Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.	NCOA2 PPARGC1A	6.24e-06	4	36	2	19462000
Pubmed	Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein.	SPAG9 MAPK8IP3	6.24e-06	4	36	2	11106729
Pubmed	Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.	NCOA2 NCOA1	6.24e-06	4	36	2	19095746
Pubmed	Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha.	NCOA2 NCOA1	6.24e-06	4	36	2	10594042
Pubmed	Transcriptional synergism on the pS2 gene promoter between a p160 coactivator and estrogen receptor-alpha depends on the coactivator subtype, the type of estrogen response element, and the promoter context.	NCOA2 NCOA1	6.24e-06	4	36	2	12403846
Pubmed	Deoxyribonucleic acid response element-dependent regulation of transcription by orphan nuclear receptor estrogen receptor-related receptor gamma.	NCOA2 PPARGC1A	6.24e-06	4	36	2	14645497
Pubmed	Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy.	NCOA2 NCOA1	6.24e-06	4	36	2	22560224
Pubmed	A simple method to screen ligands of peroxisome proliferator-activated receptor delta.	NCOA2 NCOA1	6.24e-06	4	36	2	16930961
Pubmed	Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.	NCOA2 NCOA1	6.24e-06	4	36	2	26267537
Pubmed	Isoform-specific transcriptional regulation by thyroid hormone receptors: hormone-independent activation operates through a steroid receptor mode of co-activator interaction.	NCOA2 NCOA1	6.24e-06	4	36	2	11435616
Pubmed	Activation of PPARgamma coactivator-1 through transcription factor docking.	NCOA1 PPARGC1A	6.24e-06	4	36	2	10558993
Pubmed	Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD.	NCOA2 NCOA1	6.24e-06	4	36	2	15563453
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 SMARCA4 NCOA1 TNRC18 RBM17	8.12e-06	268	36	5	33640491
Pubmed	LZTR1 is a regulator of RAS ubiquitination and signaling.	TNIK ROCK1 ADD3 MINK1	9.12e-06	127	36	4	30442766
Pubmed	Transcription activation by the orphan nuclear receptor, chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI). Definition of the domain involved in the glucocorticoid response of the phosphoenolpyruvate carboxykinase gene.	NCOA2 NCOA1	1.04e-05	5	36	2	10652338
Pubmed	Redundant enhancement of mouse constitutive androstane receptor transactivation by p160 coactivator family members.	NCOA2 NCOA1	1.04e-05	5	36	2	17950690
Pubmed	SIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasm.	NCOA2 NCOA1	1.04e-05	5	36	2	17476305
Pubmed	Sunday Driver/JIP3 binds kinesin heavy chain directly and enhances its motility.	KIF5B MAPK8IP3	1.04e-05	5	36	2	21750526
Pubmed	Ontogeny of steroid receptor coactivators in the hippocampus and their role in regulating postnatal HPA axis function.	NCOA2 NCOA1	1.04e-05	5	36	2	17854779
Pubmed	Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes.	NCOA2 NCOA1	1.04e-05	5	36	2	18511550
Pubmed	Ternary complexes and cooperative interplay between NCoA-62/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription.	NCOA2 NCOA1	1.04e-05	5	36	2	11514567
Pubmed	Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.	NCOA2 NCOA1	1.04e-05	5	36	2	11014206
Pubmed	Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells.	NCOA2 NCOA1	1.04e-05	5	36	2	14993927
Pubmed	BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation.	SMARCA4 NCOA1	1.04e-05	5	36	2	11003650
Pubmed	Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.	NCOA2 NCOA1	1.04e-05	5	36	2	12714702
Pubmed	Regulation of transcription by a protein methyltransferase.	NCOA2 NCOA1	1.04e-05	5	36	2	10381882
Pubmed	Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1.	NCOA2 NCOA1	1.04e-05	5	36	2	15721253
Pubmed	SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells.	NCOA2 NCOA1	1.04e-05	5	36	2	12514218
Pubmed	Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.	NCOA2 NCOA1	1.04e-05	5	36	2	11376110
Pubmed	Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.	NCOA2 NCOA1	1.04e-05	5	36	2	12554772
Pubmed	RBCK1, an E3 ubiquitin ligase, interacts with and ubiquinates the human pregnane X receptor.	NCOA2 NCOA1	1.04e-05	5	36	2	23160820
Pubmed	SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4.	NCOA2 NCOA1	1.04e-05	5	36	2	9812974
Pubmed	Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.	NCOA1 PPARGC1A	1.04e-05	5	36	2	16455805
Pubmed	The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.	NCOA2 NCOA1	1.04e-05	5	36	2	10757795
Pubmed	Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.	NCOA2 SMARCA4	1.04e-05	5	36	2	14966121
Pubmed	2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts.	NCOA2 NCOA1	1.04e-05	5	36	2	12796488
Pubmed	Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.	NCOA1 PPARGC1A	1.04e-05	5	36	2	12754525
Pubmed	Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.	NCOA1 PPARGC1A	1.04e-05	5	36	2	17011503
Interaction	H2BC8 interactions	SMARCA4 UPF3B TRMT6 CCDC59 ITGA4 SRCAP INCENP NSRP1 RSF1	5.65e-07	576	36	9	int:H2BC8
Interaction	PPARD interactions	CEP350 NCOA2 NCOA1 PPARGC1A TRMT6	1.98e-06	117	36	5	int:PPARD
Interaction	EP300 interactions	NCOA2 SMARCA4 NCOA1 PPARGC1A ROCK1 SPAG9 KIF5B SRCAP CLPB MAPK8IP3 RSF1 RBM17	3.17e-06	1401	36	12	int:EP300
Interaction	TERF2IP interactions	NCOA2 SMARCA4 ZBTB2 TRMT6 SRCAP INCENP NSRP1 RSF1	4.63e-06	552	36	8	int:TERF2IP
Interaction	NAA40 interactions	TNIK SMARCA4 SPAG9 UPF3B KIF5B SRCAP NSRP1 ADD3 RSF1 RBM17	5.55e-06	978	36	10	int:NAA40
Interaction	ARF6 interactions	TNIK ROCK1 SPAG9 UPF3B ITGA4 ATP8B2 ADD3 MINK1	7.00e-06	584	36	8	int:ARF6
Interaction	NRIP1 interactions	NCOA2 NCOA1 PPARGC1A CLPB MAPK8IP3	1.23e-05	170	36	5	int:NRIP1
Interaction	SOX7 interactions	NCOA2 SMARCA4 NCOA1 TNRC18	1.36e-05	82	36	4	int:SOX7
Interaction	NR4A2 interactions	SMARCA4 NCOA1 PPARGC1A	1.49e-05	27	36	3	int:NR4A2
Interaction	STAT6 interactions	NCOA2 SMARCA4 NCOA1 ZBTB2	1.72e-05	87	36	4	int:STAT6
Interaction	RAP2A interactions	TNIK NCOA1 TRMT6 MINK1	2.05e-05	91	36	4	int:RAP2A
Interaction	PPARA interactions	CEP350 NCOA2 NCOA1 PPARGC1A	2.14e-05	92	36	4	int:PPARA
Interaction	CARM1 interactions	TNIK NCOA2 SMARCA4 NCOA1 KIF5B SRCAP	2.18e-05	325	36	6	int:CARM1
Interaction	ACTC1 interactions	SMARCA4 ITGA4 SRCAP NEXN ATP8B2 NSRP1 ADD3 RBM17	2.44e-05	694	36	8	int:ACTC1
Interaction	NR5A2 interactions	NCOA2 NCOA1 PPARGC1A	5.33e-05	41	36	3	int:NR5A2
Interaction	OGA interactions	PPARGC1A SPAG9 KIF5B CLPB	8.05e-05	129	36	4	int:OGA
Interaction	NR1I3 interactions	NCOA2 NCOA1 PPARGC1A	8.57e-05	48	36	3	int:NR1I3
Interaction	NR1I2 interactions	NCOA2 NCOA1 PPARGC1A	8.57e-05	48	36	3	int:NR1I2
Interaction	SMCO1 interactions	SPAG9 MAPK8IP3	8.63e-05	8	36	2	int:SMCO1
Interaction	AHR interactions	NCOA2 SMARCA4 NCOA1 ROCK1	8.80e-05	132	36	4	int:AHR
Interaction	WWTR1 interactions	NCOA2 SMARCA4 SPAG9 KIF5B SRCAP ADD3	9.30e-05	422	36	6	int:WWTR1
Interaction	NCOA2 interactions	NCOA2 NCOA1 KIF5B SRCAP	1.14e-04	141	36	4	int:NCOA2
Interaction	HNF4A interactions	NCOA2 SMARCA4 NCOA1 PPARGC1A SRCAP	1.22e-04	275	36	5	int:HNF4A
Interaction	NCOA1 interactions	NCOA2 SMARCA4 NCOA1 PPARGC1A	1.30e-04	146	36	4	int:NCOA1
Interaction	NR1H3 interactions	CEP350 NCOA1 PPARGC1A	1.51e-04	58	36	3	int:NR1H3
Interaction	H3C1 interactions	SMARCA4 SPAG9 TNRC18 ITGA4 SRCAP INCENP NSRP1 RSF1	1.53e-04	901	36	8	int:H3C1
Interaction	CIT interactions	TNIK SMARCA4 UPF3B ITGA4 CLPB INCENP HLA-C NEXN RSF1 RBM17	1.62e-04	1450	36	10	int:CIT
Interaction	MCAM interactions	TNIK ROCK1 ITGA4 HLA-C ADD3 MINK1	1.64e-04	468	36	6	int:MCAM
Interaction	NR5A1 interactions	NCOA2 NCOA1 PPARGC1A	1.67e-04	60	36	3	int:NR5A1
Interaction	PPARG interactions	CEP350 NCOA2 SMARCA4 NCOA1 PPARGC1A	2.03e-04	307	36	5	int:PPARG
Interaction	NFKB1 interactions	NCOA1 PPARGC1A SPAG9 KIF5B RSF1	2.03e-04	307	36	5	int:NFKB1
Interaction	H3C3 interactions	SMARCA4 TRMT6 ITGA4 SRCAP INCENP RSF1	2.22e-04	495	36	6	int:H3C3
Interaction	RXRA interactions	NCOA2 SMARCA4 NCOA1 PPARGC1A	2.28e-04	169	36	4	int:RXRA
Interaction	ESRRA interactions	NCOA2 NCOA1 PPARGC1A	2.32e-04	67	36	3	int:ESRRA
Interaction	SART1 interactions	TNIK SPAG9 UPF3B NSRP1 RBM17	2.36e-04	317	36	5	int:SART1
Interaction	NR1H2 interactions	NCOA2 SMARCA4 NCOA1	2.42e-04	68	36	3	int:NR1H2
Interaction	KAT6A interactions	CEP350 SMARCA4 UPF3B ZBTB2 RSF1 RBM17	2.61e-04	510	36	6	int:KAT6A
Interaction	WDHD1 interactions	NCOA2 NCOA1 SPAG9 UPF3B	2.72e-04	177	36	4	int:WDHD1
Interaction	H3-3A interactions	SMARCA4 SPAG9 TRMT6 ITGA4 SRCAP INCENP RSF1	3.10e-04	749	36	7	int:H3-3A
Interaction	MYOD1 interactions	NCOA2 SMARCA4 NCOA1 PPARGC1A	3.85e-04	194	36	4	int:MYOD1
Interaction	ANK3 interactions	TNIK SPAG9 NEXN MAPK8IP3	4.41e-04	201	36	4	int:ANK3
Interaction	MED17 interactions	SMARCA4 PPARGC1A ROCK1 SRCAP	4.49e-04	202	36	4	int:MED17
Interaction	GALNT13 interactions	TNIK MINK1	4.66e-04	18	36	2	int:GALNT13
Interaction	ADAM28 interactions	ITGA4 ADAM28	4.66e-04	18	36	2	int:ADAM28
Interaction	CREBBP interactions	NCOA2 SMARCA4 NCOA1 PPARGC1A ZBTB2 SRCAP	6.13e-04	599	36	6	int:CREBBP
Interaction	RHOB interactions	TNIK ROCK1 UPF3B CCDC59 HLA-C ADD3 MINK1	6.17e-04	840	36	7	int:RHOB
Interaction	H3C6 interactions	SMARCA4 ITGA4 NSRP1 RBM17	6.84e-04	226	36	4	int:H3C6
Interaction	HDLBP interactions	TNIK SMARCA4 UPF3B KIF5B CCDC59 ADD3 RBM17	6.86e-04	855	36	7	int:HDLBP
Interaction	KIF5A interactions	TNIK NCOA2 KIF5B	7.09e-04	98	36	3	int:KIF5A
Cytoband	22q13.31	PKDREJ SMC1B	6.05e-04	46	36	2	22q13.31
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 NCOA1	1.90e-04	17	22	2	486
GeneFamily	Basic helix-loop-helix proteins	NCOA2 NCOA1	7.83e-03	110	22	2	420
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CEP350 PPARGC1A KIF5B CCDC59 NSRP1 ADD3 RSF1 RBM17	2.40e-06	656	36	8	M18979
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	ROCK1 TNRC18 MINK1 RSF1 CPLX2	8.83e-06	206	36	5	M2817
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	ROCK1 TNRC18 MINK1 RSF1 CPLX2	9.26e-06	208	36	5	MM581
Coexpression	FEVR_CTNNB1_TARGETS_DN	ROCK1 TRMT6 KIF5B INCENP ADD3 RSF1	9.95e-05	555	36	6	M2343
Coexpression	GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	PSTPIP1 ITGA4 ADD3 MAPK8IP3	1.48e-04	196	36	4	M6111
Coexpression	GSE40273_XBP1_KO_VS_WT_TREG_DN	CEP350 ITGA4 DENND11 ATP8B2	1.57e-04	199	36	4	M9124
Coexpression	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	ROCK1 UPF3B DENND11 RSF1	1.60e-04	200	36	4	M5069
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN	CEP350 NCOA1 SRCAP ATP8B2	1.60e-04	200	36	4	M3965
Coexpression	GSE17721_POLYIC_VS_CPG_16H_BMDC_UP	NCOA1 TNRC18 PKDREJ ADD3	1.60e-04	200	36	4	M3950
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	ROCK1 HLA-C ADD3 RSF1	1.60e-04	200	36	4	M7444
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	PPARGC1A ROCK1 KIF5B HLA-C RSF1 RBM17	4.45e-06	259	36	6	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	ROCK1 ZBTB2 KIF5B INCENP NSRP1 RSF1 RBM17	1.18e-05	469	36	7	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	CEP350 TNIK NCOA2 KIF5B ADD3	3.89e-07	186	36	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	CEP350 UPF3B NEXN NSRP1 RSF1	5.16e-07	197	36	5	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ITGA4 EXD1 ATP8B2	6.61e-06	151	36	4	d19fc363ba1d7ff77e0adcaacafa4c64e1143f40
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEP350 ITGA4 RSF1 CPLX2	1.47e-05	185	36	4	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	systemic_lupus_erythematosus-treated\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ROCK1 ITGA4 HLA-C ADD3	1.92e-05	198	36	4	8165ff735095c52994fb5057d89be93cc378b7da
ToppCell	COVID-CD4\|COVID / Condition, Cell_class and T cell subcluster	TNIK ITGA4 ATP8B2 ADD3	1.92e-05	198	36	4	3b72d3fa96f8cda528c483afdff391385113080d
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	CEP350 ROCK1 NSRP1 RSF1	1.96e-05	199	36	4	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	CEP350 ROCK1 NSRP1 RSF1	1.96e-05	199	36	4	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CEP350 ROCK1 SPAG9 ITGA4	2.00e-05	200	36	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS-antiTNF-Myeloid-Myeloid_granulocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA2012 EXD1 SMC1B	2.08e-04	143	36	3	4a0f26eef935fe68a1da5d319503059a8a8682dd
ToppCell	LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA2012 EXD1 SMC1B	2.08e-04	143	36	3	65328a0a2f3972fac596e07933e74b2ef7cceb84
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITGA4 KIAA2012 CPLX2	2.21e-04	146	36	3	b76110b159acd27a2c8d6a9f98336608ace1ec12
ToppCell	LA-15._Ventricular_Cardiomyocyte_III\|LA / Chamber and Cluster_Paper	PPARGC1A NEXN CPLX2	2.25e-04	147	36	3	8970eb6b82589f39439c61a57d999661ec8342de
ToppCell	Adult-Immune-dendritic_cell-D122\|Adult / Lineage, Cell type, age group and donor	PSTPIP1 ITGA4 ADAM28	2.58e-04	154	36	3	64a4686586d08b1e9632dde917b472ac660de2d3
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TNIK ITGA4 DENND11	2.89e-04	160	36	3	6b0faaa371650563f585722f5b2fb319e124ec38
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	SPAG9 DENND11 RBM17	2.94e-04	161	36	3	347edb0de10850b7d16c40945751033289289c9b
ToppCell	10x5'-Lung-Lymphocytic_T_CD4/8-lo\|Lung / Manually curated celltypes from each tissue	ITGA4 PKDREJ SMC1B	2.94e-04	161	36	3	a1f10e04836848b1deaf295fae033f54d1572fcd
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PSTPIP1 INCENP DENND11	3.34e-04	168	36	3	a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA4 ATP8B2 MINK1	3.34e-04	168	36	3	e979a4fbeb9f21048b47d69e6da75c57650697f2
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCHH NEXN CPLX2	3.39e-04	169	36	3	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-club_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCHH EXD1 ADAM28	3.45e-04	170	36	3	6de3778e8257c3330db0780c59238ca501fe5059
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-club_cell-club_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCHH EXD1 ADAM28	3.45e-04	170	36	3	60887da674ef1a735bad618235608312d8de63d3
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TNIK ITGA4 ADAM28	3.57e-04	172	36	3	3a76cfb2832790144a6da6406469ead0767916b5
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INCENP NEXN SMC1B	3.57e-04	172	36	3	c06ca5d075937747952ed915c9db39a9f62072f9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 ADAM28	3.63e-04	173	36	3	73f858f2c45d19b9ec8d99ac02c91551790f670c
ToppCell	Immune_cells-pro-B\|World / Lineage and Cell class	SMARCA4 PPARGC1A CPLX2	3.70e-04	174	36	3	e173adbf5789dfa20f3cbc668efde5f0992ac219
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	NCOA2 ITGA4 NEXN	3.76e-04	175	36	3	2812ac2ef41d245db544697fb6da1883361c96e8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 HLA-C	3.76e-04	175	36	3	da92eb8af0c7c65fed4a1d960708240f35dd997d
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INCENP NEXN SMC1B	3.76e-04	175	36	3	a154b28b0b2180652d51d4c7d804b3b81b35899e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 HLA-C	3.76e-04	175	36	3	2f43883d7c89f09b0579a390a7431f1f9b832582
ToppCell	Dendritic_Cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	PSTPIP1 ITGA4 ADAM28	3.88e-04	177	36	3	d2cd081bdda0eba9f6f6473c4d3939e4bee3440e
ToppCell	facs-Lung-nan-3m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCHH EXD1 ADAM28	3.88e-04	177	36	3	b37d821f4f3204daf7c568ac17a0af0ba97273d6
ToppCell	facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCHH EXD1 ADAM28	3.88e-04	177	36	3	e5070934c674a46e070b0d52b9a374516bf6aea1
ToppCell	CTRL-Lymphoid-T_cell_&_NK_cell\|CTRL / Disease state, Lineage and Cell class	PSTPIP1 ITGA4 ATP8B2	3.88e-04	177	36	3	e73d8e78a96b63e27a8a7694c62b3c44ec7ecfe6
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	SPAG9 DENND11 RBM17	3.88e-04	177	36	3	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PSTPIP1 ITGA4 HLA-C	3.95e-04	178	36	3	a96941fef62c2f4533c557ef825ae3265f8f52db
ToppCell	normal_Lung-Myeloid_cells-CD163+CD14+_DCs\|normal_Lung / Location, Cell class and cell subclass	TCHH ADAM28 SMC1B	3.95e-04	178	36	3	b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCHH NEXN CPLX2	4.01e-04	179	36	3	948c2a01ec7a626c68281e6e796a9f0527a88591
ToppCell	severe-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TNIK DENND11 ATP8B2	4.08e-04	180	36	3	ac03812b1409435c55d323a7516deeac82bd3509
ToppCell	RA-17._Lymphocyte\|RA / Chamber and Cluster_Paper	ITGA4 HLA-C CPLX2	4.21e-04	182	36	3	257a7847917b6ea1d60608183d90300bfd028758
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEP350 ITGA4 CPLX2	4.21e-04	182	36	3	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	Dendritic_Cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	PSTPIP1 ITGA4 ADAM28	4.28e-04	183	36	3	499da89b4abe7b746e703cd1e5c56f9b1d97ac3c
ToppCell	moderate-Epithelial-IRC-IFNG_responsive_cell\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HLA-C PKDREJ NEXN	4.28e-04	183	36	3	4ba879552e2101a341f3224826d364ac64c72260
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ITGA4 ADD3	4.28e-04	183	36	3	317b756378a9efd8ecb754acf7273f83f996e106
ToppCell	RA-17._Lymphocyte\|World / Chamber and Cluster_Paper	ITGA4 HLA-C CPLX2	4.28e-04	183	36	3	6397f684a50346fc42cccb5afbe10350f4b2d9b0
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TNIK ITGA4 ADAM28	4.35e-04	184	36	3	ce31684772e47a294155f368e50b49753f7c8e87
ToppCell	COVID-CD4-naive_CD4\|COVID / Condition, Cell_class and T cell subcluster	TNIK ITGA4 ADD3	4.35e-04	184	36	3	00db55970d336a301035efe43a4ab4db62627f38
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEP350 ITGA4 RSF1	4.35e-04	184	36	3	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA4 ATP8B2 CPLX2	4.42e-04	185	36	3	2a8104f610fa5ce618f8105521616722462a0d42
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCA4 INCENP CPLX2	4.49e-04	186	36	3	ec6d0c29e196e374baa96dd3d506f489c959e77e
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCA4 INCENP CPLX2	4.49e-04	186	36	3	3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d
ToppCell	droplet-Tongue-nan-24m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCHH PSTPIP1 ADAM28	4.49e-04	186	36	3	18c06041c6c8a0ebac17b3c8aaebd67e652d315a
ToppCell	Healthy/Control-CD4+_CTL\|World / Disease group and Cell class	TNIK ITGA4 HLA-C	4.56e-04	187	36	3	d54d3214d77a9469e94a16c00a80626fd4953e2b
ToppCell	CF-Lymphoid-T_cell_&_NK_cell\|Lymphoid / Disease state, Lineage and Cell class	TNIK PSTPIP1 ITGA4	4.63e-04	188	36	3	15057036b46c9df621ec4955aa94ca3036245d45
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK1 SPAG9 KIF5B	4.63e-04	188	36	3	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	TNIK PPARGC1A NEXN	4.63e-04	188	36	3	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGA4 ATP8B2 ADAM28	4.63e-04	188	36	3	567b08514d9d84cbb40f9b7a679eec304f023428
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK PSTPIP1 ITGA4	4.70e-04	189	36	3	d05e043d0874b8563b9f5514f6c884b35c603e3a
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	PPARGC1A NEXN MAPK8IP3	4.70e-04	189	36	3	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMARCA4 ITGA4 ADD3	4.78e-04	190	36	3	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	COPD-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	NCOA2 ITGA4 ADD3	4.78e-04	190	36	3	ed978cd5d9da87b49878a330e362762c487f849f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ITGA4 ADD3	4.78e-04	190	36	3	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	PPARGC1A NEXN MAPK8IP3	4.78e-04	190	36	3	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	TNIK PPARGC1A NEXN	4.78e-04	190	36	3	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PSTPIP1 ITGA4 HLA-C	4.78e-04	190	36	3	ce049630ed69d31f00acbc1b5b0896efc592121f
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_CD8+_T\|metastatic_Brain / Location, Cell class and cell subclass	PSTPIP1 ITGA4 HLA-C	4.85e-04	191	36	3	b98367fdb56ccb335d61035e69cd43c61a7fa816
ToppCell	NS-control-d_0-4-Lymphoid-CTL\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PSTPIP1 ITGA4 ATP8B2	4.85e-04	191	36	3	27f2151da2f41015a979499f274ab1284a36189f
ToppCell	control-Lymphoid-CTL\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PSTPIP1 ITGA4 ATP8B2	4.85e-04	191	36	3	8df23473e24cfa51c09986102ddd391ed0f0b9cc
ToppCell	NS-critical-d_07-13-Lymphoid-Treg\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TNIK ITGA4 ATP8B2	4.92e-04	192	36	3	cd34defac6565d34db507918e791b09c79f7d1f8
ToppCell	NS-moderate-d_07-13-Lymphoid-CTL\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PSTPIP1 ITGA4 ATP8B2	4.92e-04	192	36	3	ab2c3d829f5cbf4eb386babcfdf851222a2a88e8
ToppCell	ASK428-Immune-T_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	ITGA4 HLA-C ATP8B2	4.92e-04	192	36	3	121cb8c61002f20e1d287b8a7e67a30bb163e74a
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	TNIK PPARGC1A NEXN	4.92e-04	192	36	3	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PSTPIP1 ITGA4 HLA-C	4.92e-04	192	36	3	edb0f4fff3a9d7af5e71d3a282f358cf04ca1435
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCA4 INCENP CPLX2	5.00e-04	193	36	3	9c2f58b4c89dc084a1a6e53952ea793e87a96660
ToppCell	moderate-Lymphoid-CTL\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PSTPIP1 ITGA4 ATP8B2	5.00e-04	193	36	3	3fce0807631811da1cff5ca9db23ff1ad36020e7
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	TNIK PPARGC1A NEXN	5.00e-04	193	36	3	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	ASK428-Immune-T_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	ITGA4 ATP8B2 ADD3	5.00e-04	193	36	3	bca9bf941193feea8ed56735041513185c165135
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCA4 INCENP CPLX2	5.00e-04	193	36	3	db881cc129b45031fd84d052768cef53508de196
ToppCell	T_cells-Central_memory_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	TNIK ATP8B2 ADD3	5.00e-04	193	36	3	725326d7e3604736b607c19f4069c81cb4f2d20c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 ADAM28	5.08e-04	194	36	3	96f16bcd393a0d3f8df479b172b5360ae5a1e663
ToppCell	NS-moderate-d_16-33-Lymphoid-CTL\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PSTPIP1 ITGA4 ATP8B2	5.08e-04	194	36	3	6b2bb3dd11fd53fa9ab4d66c18b0714f96f99288
ToppCell	Healthy_donor-CD8+_Tem\|Healthy_donor / disease group, cell group and cell class (v2)	TNIK ITGA4 HLA-C	5.08e-04	194	36	3	bf2e889de60b2b452a41f4d59a0f2a1865f07184
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PSTPIP1 ITGA4 HLA-C	5.08e-04	194	36	3	9344556b375fd9267652cdca57b2cbd50a878a1e
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PSTPIP1 ITGA4 HLA-C	5.08e-04	194	36	3	13c3674d601c8a7355ce869de1af6401938c0037
ToppCell	Bronchial_Brush-Immune-Dendritic_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	SPAG9 ITGA4 ADAM28	5.08e-04	194	36	3	dbcc00940538efc0f89f074dbe822c50efa5ad8e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 ADAM28	5.08e-04	194	36	3	0866ab6792cee274a71991d5c37a37f574ff446e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 ADAM28	5.15e-04	195	36	3	91a3c439f10c03c5d51d904f512b6a08040edc76
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	TNIK PPARGC1A NEXN	5.15e-04	195	36	3	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ITGA4 ADD3	5.15e-04	195	36	3	e06ff785c5542c86c335d956799e03f7ae8345a4
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 HLA-C	5.15e-04	195	36	3	deadfbc25e922c967b96bdbed4e7b16ff77ee132
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PSTPIP1 ITGA4 HLA-C	5.15e-04	195	36	3	6774c9f7fa54045aaa35fbd0695e43748da2b293
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 ADAM28	5.15e-04	195	36	3	ce8215d503cad3a9bc7d5d2be4adb57408015593
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 ADAM28	5.15e-04	195	36	3	2d485373bfd9bb4bb9236bf0b31d03e132c8018f
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PSTPIP1 ITGA4 HLA-C	5.15e-04	195	36	3	073593a7f668512d1fbbb49efb0c20b736c79ff8
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TNIK ATP8B2 ADD3	5.15e-04	195	36	3	4bdedd924564a260841a9153604026b57487c83d
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TNIK ATP8B2 ADD3	5.15e-04	195	36	3	22191d361af136942508f1553ff41a626ed982ad
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PSTPIP1 ITGA4 ADAM28	5.15e-04	195	36	3	09df40ff9b493170861b3f6e57a942a834655b5c
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCA4 INCENP CPLX2	5.15e-04	195	36	3	5749ea833be84e262e3d0a4fe1a9a373f0ef545f
ToppCell	Healthy/Control-CD8+_Tem\|Healthy/Control / Disease group and Cell class	TNIK ITGA4 HLA-C	5.15e-04	195	36	3	f4955c176c4918052dc151c5e5249223ec428272
ToppCell	CV-Moderate-6\|Moderate / Virus stimulation, Condition and Cluster	CEP350 NCOA1 ROCK1	5.15e-04	195	36	3	2b8a72d7e755b9655c7a496000d10ff06e50862b
Computational	Genes upregulated in subsets of cells of a given type within various tumors	CEP350 ROCK1 ITGA4	1.48e-04	49	23	3	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Neighborhood of MAP4K4	CEP350 TNIK SPAG9 MAPK8IP3	4.42e-04	172	23	4	GCM_MAP4K4
Drug	2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3	NCOA2 NCOA1 PPARGC1A	5.44e-07	11	35	3	ctd:C061137
Drug	dihydroxy-vitamin D3	NCOA2 NCOA1 PPARGC1A	9.42e-07	13	35	3	ctd:C118756
Drug	homopiperazine	ROCK1 PSTPIP1 ITGA4	7.48e-06	25	35	3	CID000068163
Drug	lithocholic acid acetate	NCOA2 NCOA1 PPARGC1A	8.44e-06	26	35	3	ctd:C502354
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; PC3; HT_HG-U133A	TNIK SRCAP INCENP ATP8B2 MINK1	1.18e-05	196	35	5	4574_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	NCOA2 TCHH INCENP ATP8B2 MINK1	1.21e-05	197	35	5	5201_DN
Drug	Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A	CEP350 NCOA1 ATP8B2 MINK1 MAPK8IP3	1.30e-05	200	35	5	5782_DN
Drug	Magnetite Nanoparticles	NCOA2 ROCK1 SPAG9 ZBTB2 TRMT6 KIF5B ITGA4 ADAM28 ADD3 RSF1	1.88e-05	1310	35	10	ctd:D058185
Drug	butamben	NCOA2 NCOA1	3.43e-05	6	35	2	ctd:C004605
Drug	2',3',4',5'-tetrachloro-4-biphenylol	NCOA2 NCOA1	3.43e-05	6	35	2	ctd:C104006
Drug	Isoxazoles	NCOA1 PPARGC1A	6.39e-05	8	35	2	ctd:D007555
Drug	2-acetyltributylcitrate	NCOA2 NCOA1	8.21e-05	9	35	2	ctd:C014953
Drug	tris(chloroethyl)phosphate	NCOA2 NCOA1 PPARGC1A	8.26e-05	55	35	3	ctd:C031324
Drug	Succimer	NCOA2 ROCK1 SPAG9 TRMT6 KIF5B ITGA4 ADAM28 ADD3 RSF1	9.25e-05	1264	35	9	ctd:D004113
Drug	GGTI-298	SMARCA4 ROCK1 ITGA4	1.24e-04	63	35	3	CID009811606
Drug	Androstenols	NCOA2 NCOA1	1.50e-04	12	35	2	ctd:D000737
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	CEP350 SMARCA4 KIF5B ADD3	1.53e-04	177	35	4	985_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	SMARCA4 SPAG9 KIF5B ADD3	1.60e-04	179	35	4	4585_DN
Drug	LFA703	ROCK1 ITGA4	1.77e-04	13	35	2	CID000449169
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A	TNIK SMARCA4 SPAG9 INCENP	2.05e-04	191	35	4	4647_DN
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; HL60; HT_HG-U133A	NCOA1 PSTPIP1 SRCAP ATP8B2	2.05e-04	191	35	4	2499_DN
Drug	Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A	UPF3B ITGA4 ADD3 MINK1	2.09e-04	192	35	4	1365_DN
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	NCOA1 SRCAP MINK1 MAPK8IP3	2.09e-04	192	35	4	1165_UP
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A	ITGA4 SRCAP ADAM28 MINK1	2.13e-04	193	35	4	4306_UP
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	NCOA2 SRCAP INCENP MAPK8IP3	2.13e-04	193	35	4	3811_UP
Drug	Clotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ITGA4 SRCAP MINK1 MAPK8IP3	2.13e-04	193	35	4	3166_UP
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; HL60; HG-U133A	NCOA2 NCOA1 UPF3B KIF5B	2.18e-04	194	35	4	1409_DN
Drug	lomustine; Down 200; 100uM; MCF7; HT_HG-U133A	SMARCA4 SRCAP ADD3 MINK1	2.18e-04	194	35	4	7089_DN
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	CEP350 SRCAP MINK1 MAPK8IP3	2.18e-04	194	35	4	5457_DN
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	NCOA2 SPAG9 INCENP MINK1	2.18e-04	194	35	4	7538_DN
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SRCAP INCENP ATP8B2 MAPK8IP3	2.18e-04	194	35	4	7423_DN
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A	NCOA1 SRCAP ATP8B2 MINK1	2.22e-04	195	35	4	3850_DN
Drug	Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A	NCOA2 SRCAP INCENP MAPK8IP3	2.22e-04	195	35	4	4737_DN
Drug	Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	NCOA2 TCHH SRCAP MINK1	2.22e-04	195	35	4	3452_UP
Drug	Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A	TNIK SRCAP ATP8B2 ADAM28	2.22e-04	195	35	4	2962_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; HL60; HG-U133A	SMARCA4 ITGA4 CLPB MAPK8IP3	2.26e-04	196	35	4	1593_DN
Drug	Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NCOA1 TCHH ATP8B2 MINK1	2.26e-04	196	35	4	5636_DN
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A	NCOA2 SPAG9 ATP8B2 MINK1	2.26e-04	196	35	4	1494_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; HL60; HG-U133A	CEP350 MINK1 MAPK8IP3 RSF1	2.26e-04	196	35	4	1444_DN
Drug	Pivampicillin [33817-20-8]; Down 200; 8.6uM; HL60; HT_HG-U133A	SMARCA4 NCOA1 ITGA4 CLPB	2.31e-04	197	35	4	2945_DN
Drug	E)-4-hydroxytamoxifen	NCOA2 SMARCA4 NCOA1 PPARGC1A	2.31e-04	197	35	4	CID000063062
Drug	Proglumide [6620-60-6]; Down 200; 12uM; HL60; HT_HG-U133A	NCOA1 SPAG9 ATP8B2 MAPK8IP3	2.31e-04	197	35	4	2363_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	INCENP ATP8B2 MINK1 MAPK8IP3	2.31e-04	197	35	4	3566_DN
Drug	Leflunomide [75706-12-6]; Down 200; 14.8uM; PC3; HT_HG-U133A	SMARCA4 SPAG9 INCENP MINK1	2.31e-04	197	35	4	5884_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	INCENP ATP8B2 MINK1 MAPK8IP3	2.31e-04	197	35	4	5211_DN
Drug	Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SMARCA4 ATP8B2 MINK1 MAPK8IP3	2.31e-04	197	35	4	7434_DN
Drug	DAPH; Down 200; 10uM; MCF7; HG-U133A	CEP350 SMARCA4 ROCK1 ADD3	2.31e-04	197	35	4	624_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	NCOA2 SRCAP MINK1 MAPK8IP3	2.31e-04	197	35	4	4730_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A	ITGA4 SRCAP MAPK8IP3 CPLX2	2.35e-04	198	35	4	3810_UP
Drug	Acetazolamide [59-66-5]; Up 200; 18uM; HL60; HT_HG-U133A	NCOA2 SRCAP INCENP ATP8B2	2.35e-04	198	35	4	1850_UP
Drug	Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; HL60; HG-U133A	CEP350 PSTPIP1 ITGA4 RSF1	2.35e-04	198	35	4	1596_DN
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A	NCOA2 SPAG9 SRCAP RSF1	2.35e-04	198	35	4	2256_DN
Drug	Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A	CEP350 NCOA1 CLPB MAPK8IP3	2.40e-04	199	35	4	1568_DN
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; HL60; HG-U133A	ITGA4 SRCAP MAPK8IP3 RSF1	2.40e-04	199	35	4	1994_UP
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; PC3; HT_HG-U133A	TNIK NCOA1 SRCAP CLPB	2.40e-04	199	35	4	7267_DN
Drug	Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A	TNIK ADAM28 MAPK8IP3 CPLX2	2.44e-04	200	35	4	3623_UP
Drug	Minoxidil [38304-91-5]; Up 200; 19.2uM; PC3; HG-U133A	TNIK SRCAP MINK1 MAPK8IP3	2.44e-04	200	35	4	1914_UP
Drug	dexamethasone 21-mesylate	NCOA2 NCOA1	2.72e-04	16	35	2	CID000063041
Drug	ferutinin	NCOA2 NCOA1	2.72e-04	16	35	2	CID000354654
Drug	tris(2-butoxyethyl) phosphate	NCOA2 NCOA1 PPARGC1A	2.91e-04	84	35	3	ctd:C013320
Drug	CV-1	NCOA2 NCOA1 PPARGC1A KIF5B	3.11e-04	213	35	4	CID000130105
Drug	1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole	NCOA1 PPARGC1A	3.46e-04	18	35	2	ctd:C524478
Drug	androst-2-en-3-ol	NCOA2 NCOA1	3.46e-04	18	35	2	CID000166036
Disease	diabetic retinopathy (implicated_via_orthology)	PPARGC1A ITGA4	1.72e-04	16	36	2	DOID:8947 (implicated_via_orthology)
Disease	lung non-small cell carcinoma (is_implicated_in)	NCOA2 SMARCA4 ADAM28	6.52e-04	139	36	3	DOID:3908 (is_implicated_in)
Disease	Burkitt Lymphoma	SMARCA4 HLA-C	8.88e-04	36	36	2	C0006413
Disease	prostate cancer (is_marker_for)	NCOA2 SMARCA4 NCOA1	9.11e-04	156	36	3	DOID:10283 (is_marker_for)
Disease	QRS amplitude, QRS complex	CCDC59 NSRP1	1.71e-03	50	36	2	EFO_0005054, EFO_0007742
Disease	response to cisplatin	TNRC18 CCDC59	1.78e-03	51	36	2	GO_0072718
Disease	neutrophil count, basophil count	NCOA1 ITGA4 HLA-C	2.56e-03	224	36	3	EFO_0004833, EFO_0005090
Disease	breast carcinoma (is_marker_for)	NCOA1 ADAM28	2.96e-03	66	36	2	DOID:3459 (is_marker_for)
Disease	parental longevity	CEP350 SMARCA4 PPARGC1A HLA-C	2.99e-03	494	36	4	EFO_0007796
Disease	Manic Disorder	ADD3 CPLX2	3.41e-03	71	36	2	C0024713
Disease	Manic	ADD3 CPLX2	4.10e-03	78	36	2	C0338831
Disease	Depression, Bipolar	ADD3 CPLX2	4.20e-03	79	36	2	C0005587

Protein segments in the cluster

Peptide	Gene	Start	Entry
EFKRYNENQDEIRKR	ADAM28	216	Q9UKQ2
VLEKRNKIREQNRYD	ADD3	501	Q9UEY8
EERRARANDREYNEK	ATP8B2	31	P98198
EKDREKYSQREQERD	NSRP1	381	Q9H0G5
ERYENNDKYRDREKR	NSRP1	426	Q9H0G5
RDEKQRRKEQYIRER	NEXN	51	Q0ZGT2
DRKRYQQEVDRIKEA	KIF5B	891	P33176
RREQKREQYRQVKAH	SPAG9	621	O60271
EEFRERQKEQRKKYE	PSTPIP1	106	O43586
EQKREQYRQVREHVR	MAPK8IP3	641	Q9UPT6
RKKRRISYVQDENRD	INCENP	66	Q9NQS7
QKQRREKAAREYRVN	EXD1	311	Q8NHP7
RETQKYKRQAQADRV	HLA-C	86	P10321
RLEYQRRKQEAEEKA	KIAA2012	1126	Q0VF49
RREYEKRESERAKQR	PPARGC1A	651	Q9UBK2
LKRQEEERRRQKERY	UPF3B	366	Q9BZI7
ADREKYRRLNEQRQM	DENND11	356	A4D1U4
VRQYIVRQQEERKRK	CEP350	596	Q5VT06
KRQYKSILQEENRRD	ITGA4	1006	P13612
KYQEKQRKREAEERR	CLPB	321	Q9H078
RSRRNQKRQINYKED	RSF1	1206	Q96T23
EAEREKVRQQIRDKY	CPLX2	56	Q6PUV4
ERRQAEREQEYKRKQ	MINK1	441	Q8N4C8
EREQEYKRKQLEEQR	MINK1	446	Q8N4C8
TEKRRREQENKYLEE	NCOA1	31	Q15788
NRQEQTESRERKYMR	PKDREJ	1411	Q9NTG1
KIEQERKRRQKHQEY	SMARCA4	461	P51532
ERRKQEREEAQRQYK	CCDC59	191	Q9P031
QRQKEERARREEQAK	SRCAP	176	Q6ZRS2
KRNTEKRNREQENKY	NCOA2	31	Q15596
RLAEVQRQYKEKQRE	TNRC18	1486	O15417
RKQQEREQRRHYEEQ	TNIK	416	Q9UKE5
RRQAKLEKEEAERYQ	SMC1B	196	Q8NDV3
NDYEKVVKRQREERQ	RBM17	106	Q96I25
NEYQRKAEQENEKRR	ROCK1	496	Q13464
DYIQEKQRRQEEQRK	TRMT6	341	Q9UJA5
QADQEREVKRRKYEC	ZBTB2	351	Q8N680
EEREKRRRQEQERQY	TCHH	916	Q07283
EEREKRRRQERERQY	TCHH	946	Q07283
EEQEKRRQERERQYR	TCHH	1186	Q07283
ERQYREEEELQRQKR	TCHH	1196	Q07283
EEEELQRQKRKQRYR	TCHH	1201	Q07283
QRQKRKQRYRDEDQR	TCHH	1206	Q07283